Athena Countouriotis
2019
In 2019, Athena Countouriotis earned a total compensation of $3.1M as President and Chief Executive Officer at Turning Point Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $429,896 |
|---|---|
| Option Awards | $2,141,297 |
| Salary | $543,912 |
| Other | $11,200 |
| Total | $3,126,305 |
Countouriotis received $2.1M in option awards, accounting for 68% of the total pay in 2019.
Countouriotis also received $429.9K in non-equity incentive plan, $543.9K in salary and $11.2K in other compensation.
Rankings
In 2019, Athena Countouriotis' compensation ranked 3,910th out of 13,971 executives tracked by ExecPay. In other words, Countouriotis earned more than 72.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,910 out of 13,971 | 72nd |
Division Manufacturing | 1,413 out of 5,701 | 75th |
Major group Chemicals And Allied Products | 496 out of 2,200 | 78th |
Industry group Drugs | 419 out of 1,886 | 78th |
Industry Pharmaceutical Preparations | 318 out of 1,398 | 77th |
Source: SEC filing on April 29, 2022.
Countouriotis' colleagues
We found three more compensation records of executives who worked with Athena Countouriotis at Turning Point Therapeutics in 2019.